Literature DB >> 29921920

Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity.

Bo Cao1,2, Raymond Y Cho3, Dachun Chen4, Meihong Xiu4, Li Wang5, Jair C Soares2, Xiang Yang Zhang6.   

Abstract

Identifying biomarkers in schizophrenia during the first episode without the confounding effects of treatment has been challenging. Leveraging these biomarkers to establish diagnosis and make individualized predictions of future treatment responses to antipsychotics would be of great value, but there has been limited progress. In this study, by using machine learning algorithms and the functional connections of the superior temporal cortex, we successfully identified the first-episode drug-naive (FEDN) schizophrenia patients (accuracy 78.6%) and predict their responses to antipsychotic treatment (accuracy 82.5%) at an individual level. The functional connections (FC) were derived using the mutual information and the correlations, between the blood-oxygen-level dependent signals of the superior temporal cortex and other cortical regions acquired with the resting-state functional magnetic resonance imaging. We also found that the mutual information and correlation FC was informative in identifying individual FEDN schizophrenia and prediction of treatment response, respectively. The methods and findings in this paper could provide a critical step toward individualized identification and treatment response prediction in first-episode drug-naive schizophrenia, which could complement other biomarkers in the development of precision medicine approaches for this severe mental disorder.

Entities:  

Keywords:  SVM; support vector machines

Mesh:

Substances:

Year:  2018        PMID: 29921920     DOI: 10.1038/s41380-018-0106-5

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  35 in total

Review 1.  Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

Authors:  Harvey A Whiteford; Louisa Degenhardt; Jürgen Rehm; Amanda J Baxter; Alize J Ferrari; Holly E Erskine; Fiona J Charlson; Rosana E Norman; Abraham D Flaxman; Nicole Johns; Roy Burstein; Christopher J L Murray; Theo Vos
Journal:  Lancet       Date:  2013-08-29       Impact factor: 79.321

2.  Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects.

Authors:  Hugo G Schnack; Mireille Nieuwenhuis; Neeltje E M van Haren; Lucija Abramovic; Thomas W Scheewe; Rachel M Brouwer; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Neuroimage       Date:  2013-09-01       Impact factor: 6.556

3.  Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group.

Authors:  R A Emsley
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

4.  Progressive brain changes in children and adolescents with early-onset psychosis: A meta-analysis of longitudinal MRI studies.

Authors:  David Fraguas; Covadonga M Díaz-Caneja; Laura Pina-Camacho; Joost Janssen; Celso Arango
Journal:  Schizophr Res       Date:  2014-12-31       Impact factor: 4.939

Review 5.  The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.

Authors:  S Moylan; M Maes; N R Wray; M Berk
Journal:  Mol Psychiatry       Date:  2012-04-24       Impact factor: 15.992

Review 6.  Setting the stage: from prodrome to treatment resistance in bipolar disorder.

Authors:  Michael Berk; Philippe Conus; Nellie Lucas; Karen Hallam; Gin S Malhi; Seetal Dodd; Lakshmi N Yatham; Alison Yung; Pat McGorry
Journal:  Bipolar Disord       Date:  2007-11       Impact factor: 6.744

Review 7.  Areas of controversy in neuroprogression in bipolar disorder.

Authors:  I C Passos; B Mwangi; E Vieta; M Berk; F Kapczinski
Journal:  Acta Psychiatr Scand       Date:  2016-04-21       Impact factor: 6.392

Review 8.  Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies.

Authors:  A Vita; L De Peri; G Deste; E Sacchetti
Journal:  Transl Psychiatry       Date:  2012-11-20       Impact factor: 6.222

Review 9.  Effectiveness of second generation antipsychotics: a systematic review of randomized trials.

Authors:  Erik Johnsen; Hugo A Jørgensen
Journal:  BMC Psychiatry       Date:  2008-04-25       Impact factor: 3.630

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  28 in total

1.  Dynamic functional connectivity and its anatomical substrate reveal treatment outcome in first-episode drug-naïve schizophrenia.

Authors:  Zhe Zhang; Kaiming Zhuo; Qiang Xiang; Yi Sun; John Suckling; Jinhong Wang; Dengtang Liu; Yu Sun
Journal:  Transl Psychiatry       Date:  2021-05-12       Impact factor: 6.222

2.  Cardiopulmonary Comorbidity, Radiomics and Machine Learning, and Therapeutic Regimens for a Cerebral fMRI Predictor Study in Psychotic Disorders.

Authors:  Xiao-Hui Wang; Angela Yu; Xia Zhu; Hong Yin; Long-Biao Cui
Journal:  Neurosci Bull       Date:  2019-07-10       Impact factor: 5.203

3.  The Translational Potential of Neuroimaging Genomic Analyses To Diagnosis And Treatment In The Mental Disorders.

Authors:  Jiayu Chen; Jingyu Liu; Vince D Calhoun
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2019-05-09       Impact factor: 10.961

4.  A multivariate neuroimaging biomarker of individual outcome to transcranial magnetic stimulation in depression.

Authors:  Robin F H Cash; Luca Cocchi; Rodney Anderson; Anton Rogachov; Aaron Kucyi; Alexander J Barnett; Andrew Zalesky; Paul B Fitzgerald
Journal:  Hum Brain Mapp       Date:  2019-07-22       Impact factor: 5.038

5.  Baseline Frontoparietal Task-Related BOLD Activity as a Predictor of Improvement in Clinical Symptoms at 1-Year Follow-Up in Recent-Onset Psychosis.

Authors:  Jason Smucny; Tyler A Lesh; Cameron S Carter
Journal:  Am J Psychiatry       Date:  2019-07-01       Impact factor: 18.112

6.  A deep learning approach in automated detection of schizophrenia using scalogram images of EEG signals.

Authors:  Zülfikar Aslan; Mehmet Akin
Journal:  Phys Eng Sci Med       Date:  2021-11-25

7.  Abnormal within- and cross-networks functional connectivity in different outcomes of herpes zoster patients.

Authors:  Ying Wu; Chao Wang; Lina Yu; Wei Qian; Xiufang Xing; Minming Zhang; Min Yan
Journal:  Brain Imaging Behav       Date:  2021-09-21       Impact factor: 3.978

8.  AI in patient flow: applications of artificial intelligence to improve patient flow in NHS acute mental health inpatient units.

Authors:  Fatema Mustansir Dawoodbhoy; Jack Delaney; Paulina Cecula; Jiakun Yu; Iain Peacock; Joseph Tan; Benita Cox
Journal:  Heliyon       Date:  2021-05-12

9.  Predicting acupuncture efficacy for functional dyspepsia based on routine clinical features: a machine learning study in the framework of predictive, preventive, and personalized medicine.

Authors:  Tao Yin; Hui Zheng; Tingting Ma; Xiaoping Tian; Jing Xu; Ying Li; Lei Lan; Mailan Liu; Ruirui Sun; Yong Tang; Fanrong Liang; Fang Zeng
Journal:  EPMA J       Date:  2022-02-02       Impact factor: 6.543

10.  Towards a brain-based predictome of mental illness.

Authors:  Barnaly Rashid; Vince Calhoun
Journal:  Hum Brain Mapp       Date:  2020-05-06       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.